** Shares of healthcare solutions provider DRAD.O fall 7%
to $2.50
** Co posts Q3 adj.loss of 19 cents/shr vs expectations of a
15 cents/shr profit - Refinitiv IBES urn:newsml:reuters.com:*:nGNXMY16c
** Q3 net loss widened to $1.8 mln vs $1.5 mln, a year
earlier
** DRAD said its Q3 operating and financial results
continued to be impacted by the slowdown due to COVID-19
** Revenue in its healthcare segment dropped 14.9% to $21.8
mln
** Marketing, sales, general and administrative expenses
increased 12.5% in the qtr
** Stock down 3.5% YTD
(Reporting by Shradha Singh in Bengaluru)
((Shradha.Singh@thomsonreuters.com; within U.S. +1 646 223 8780
Ext: 2804, outside U.S. +91 80 6182 2630;))